Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-15

Clinical Trial Update: A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the mechanism by which Glucovance (metformin and glyburide) controls blood glucose in patients with Type 2 diabetes mellitus; study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucovance (glyburide/metformin)
  • Glyburide (glyburide)
  • metformin (metformin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 4 | Status: COMPLETED